India Ratings and Research assigns rating to Wockhardt’s debt programme

02 Dec 2015 Evaluate

Credit rating agency, Indian Ratings and Research has assigned a short term rating of  ‘A1+’ to Wockhardt’s proposed Rs 1 billion commercial paper (CP)/short-term debt programme .

Wockhardt is one of the few companies with end to end integrated capabilities for its products, starting with the manufacture of the oral and sterile API’s, the dose forms and marketing through wholly owned subsidiary in the US, enabling the company to capture maximum value.

Wockhardt Share Price

1174.60 -12.05 (-1.02%)
20-Mar-2026 15:48 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1777.20
Dr. Reddys Lab 1295.00
Cipla 1260.65
Zydus Lifesciences 890.60
Lupin 2322.45
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×